🇺🇸 FDA
Pipeline program

HTX-011

HTX-011-301

Approved small_molecule completed

Quick answer

HTX-011 for Postoperative Pain is a Approved program (small_molecule) at Heron Therapeutics with 8 ClinicalTrials.gov record(s).

Program details

Company
Heron Therapeutics
Indication
Postoperative Pain
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials